Investing.com - BioLineRx reported on Monday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
BioLineRx announced earnings per share of $-0.2985 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.34 on revenue of $0.00.
BioLineRx shares are up 1.33% from the beginning of the year, still down 30.91% from its 52 week high of $3.30 set on November 3. They are under-performing the Nasdaq which is up 32.41% from the start of the year.
BioLineRx follows other major sector earnings this month
BioLineRx's report follows an earnings beat by Tencent ADR on November 12, who reported EPS of $3.31 on revenue of $125.4B, compared to forecasts EPS of $0.47 on revenue of $18.26B.
Industrial Commercial Bank of China had beat expectations on October 30 with third quarter EPS of $0.6567 on revenue of $29.54B, compared to forecast for EPS of $0.4852 on revenue of $28.59B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar